Stock Alert: NSE, V2 Retail, MCX, Lupin, Kotak Mahidra Bank
Shares of Kaynes Technology and Steel Authority of India (SAIL) are barred from F&O Trading on 4 November 2026.
Results Today:
Power Finance Corporation, Apollo Hospitals Enterprise, Aurobindo Pharma, Dabur India, Cummins India, NHPC, Torrent Power, FSN E-Commerce Ventures (Nykaa), Biocon, PI Industries, Niva Bupa Health Insurance Company, Balkrishna Industries, Housing & Urban Development Corporation, Krishna Institute of Medical Sciences and NLC India will declare their results later today.
Stocks to Watch:
National Stock Exchange of India (NSE) reported a 22.83% rise in consolidated net profit to Rs 2,577.62 crore in Q2 FY27 compared with Rs 2098.47 crore in Q2 FY26. Revenue from operations climbed 10.61% YoY to Rs 4066.80 crore in Q2 FY27.
V2 Retail reported a 5.69% jump in consolidated net profit to Rs 18.21 crore in Q2 FY27 compared with Rs 17.23 crore in Q2 FY26. Revenue from operations climbed 27.79% YoY to Rs 905.6 crore in the quarter ended 30th September 2026.
Subros? consolidated net profit increased 9.57% to Rs 44.64 crore on 36.26% rise in net sales to Rs 1198.9 crore in Q2 FY27 over Q2 FY26.
Vijaya Diagnostic Centre reported a 37.41% jump in consolidated net profit to Rs 59.47 crore in Q2 FY27 compared with Rs 43.28 crore in Q2 FY26. Revenue from operations rose 26.7% YoY to Rs 255.38 crore in Q2 FY27.
Multi Commodity Exchange of India (MCX) surged 130.2% to Rs 454.57 crore in Q2 FY27 compared with Rs 197.47 crore in Q2 FY26. Revenue from operations soared 113.68% YoY to Rs 799.66 crore in the quarter ended 30th September 2026.
Lupin announced the launch of Raltegravir Tablets USP, 600 mg in the United Statesfollowing the approval from the U.S. FDA for its Abbreviated New Drug Application. Raltegravir Tablets, 600 mg are bioequivalent to the reference listed drug (RLD) Isentress? HD Tablets, 600 mg of Merck Sharp & Dohme, LLC. and indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV-1) infection in adult patients and in pediatric patients weighing at least 40 kg.
Kotak Mahindra Bank has secured approval from the Competition Commission of India (CCI) to acquire Deutsche Bank?s retail banking, private banking and wealth management businesses in India on slump sales basis.
Powered by Capital Market - Live News